Biomarker Testing of Patients With NSCLC Can Aid Survival
Comprehensive biomarker testing of patients with non-small lung cancer (NSCLC) is a critical part...
Read More
Dissemination (Spotlight)
Apalutamide Linked With Faster Time to PSA90 Than Abiraterone Acetate
In metastatic castration-sensitive prostate cancer, patients on apalutamide were 53% more likely...
Read More
Q&A: “Initiate Open Conversations” to Manage Financial Toxicity in Prostate Cancer
Routine conversations about costs can address the financial toxicity associated with new...
Read More
Assessing Liquid Biopsy Alongside Tissue Testing in NSCLC Genotyping
Biomarker testing is crucial for managing non-small cell lung cancer (NSCLC), with plasma-based...
Read More
Patients & Physicians Want NSCLC Biomarker Education Materials
Researchers conducted a study to investigate the experiences of patients and clinicians regarding...
Read More
Comprehensive mNSCLC Biomarker Testing in Large Community Practice Feasible & Successful
A study aimed to enhance comprehensive biomarker testing for patients with metastatic...
Read More
For Metastatic NSCLC, Biomarker Testing Rates Up, But Genotyping Gaps Persist
A study aimed to analyze changes in biomarker testing among patients with metastatic non-small...
Read More
Importance of Tumor Density in Predicting Prostate Cancer on Targeted Biopsy
The following is a summary of “Role of tumor density in predicting significant cancer on targeted...
Read More
Clinical & Treatment Features of Secondary Bladder Malignancies After LDR Brachytherapy for Prostate Cancer
The following is a summary of “Clinical and treatment characteristics of secondary bladder...
Read MoreGenetic Variants Linked to TMPRSS2: ERG Fusion in Prostate Cancer
The following is a summary of “Germline genetic variants associated with somatic TMPRSS2:ERG fusion status in prostate cancer: a genome-wide association study,” published in the August 2023 issue of Oncology by Ma et...
Read More
Q&A: Five Decades of TD Research Enhance the Work of Today’s Scientists
Scientific knowledge of tardive dyskinesia (TD) over the past five decades will prove useful for...
Read More
Telehealth for Tardive Dyskinesia Has Its Benefits & Drawbacks
Assessing the benefits and drawbacks of telehealth for tardive dyskinesia exams is critical as...
Read More
Association of CSU Heterogeneity and Risk in Genome-Wide Study
The following is the summary of “A genome-wide association study of chronic spontaneous urticaria...
Read More
Low-Dose Interleukin-2 Injections Improve Chronic Spontaneous Urticaria
The following is the summary of “Consecutive injections of low-dose interleukin-2 improve symptoms...
Read More
Autoimmune Chronic Spontaneous Urticaria Linked to Autoallergic Urticaria
The following is the summary of “Most Patients With Autoimmune Chronic Spontaneous Urticaria Also...
Read More
Gender Differences Observed in Patients With Schizophrenia Who Have TD
Female gender may offer protection against the development of cognitive impairment due to tardive...
Read More
IMPACT-TD Scale Addresses ‘Critical Need’ for Assessment Tools in TD
The IMPACT-TD scale assesses four domains of functional impairment in tardive dyskinesia (TD) and...
Read More
Tardive Dyskinesia Impacts ‘Every Single Domain’ of Patients’ Lives
Tardive dyskinesia negatively impacts physical, emotional, and social functioning, which can...
Read More
TD Impacts Physical Wellness & Social Functioning
Tardive dyskinesia can lead to feelings of stigmatization and social withdrawal, as well as a...
Read More
Relationship Between Cognitive Deficits and Tardive Dyskinesia in Chronic Schizophrenia Patients: Sex Differences
The following is a summary of “Sex difference in association between tardive dyskinesia and...
Read More